Developer docs
API playgroundTry for free, no card

Search company profiles

Patel Chem Specialities

Full company profile

uuid0003tl8

Namestring
Patel Chem Specialities
Legal namestring
Patel Chem Specialities Limited
Websiteurl
pcspl.net
Company typeenum
Public
Founded yearint
2008
Descriptiontext

Patel Chem Specialities Limited is an Indian pharmaceutical excipient manufacturer and exporter, founded in 2008 and headquartered at GIDC Estate, Vatva, Ahmedabad, Gujarat. The company operates a single GMP-, ISO-, and FDA-certified manufacturing facility producing eight products: seven branded pharmaceutical excipients — Rheollose® (Carboxymethyl Cellulose Sodium), Disolwell® (Croscarmellose Sodium), BlowTab® (Sodium Starch Glycolate), Swellcal® (Calcium CMC), Hindcel® (Microcrystalline Cellulose), PharLub™ (Magnesium Stearate), and AmyloTab™ C (Pregelatinized Starch) — plus the specialty chemical Sodium Chloro Acetate. The portfolio covers superdisintegrants, binders/fillers, lubricants, and cellulose ethers, with multi-pharmacopeial compliance (IP, BP, EP, USP-NF, JP) enabling sales into both domestic Indian formulation manufacturers and export markets. The company also holds Halal India certification and an Indian Drug License, supporting nutraceutical and food-industry adjacencies.

The business operates as a B2B direct-sales manufacturer selling excipient inputs to pharmaceutical and nutraceutical formulators for tablet and capsule production. Pricing is quote-based rather than publicly listed, consistent with B2B specialty chemicals. Go-to-market relies on trade-show participation (CPHI & PMEC India 2024, FI India 2024) and a corporate website, with no distribution intermediaries. The company filed its DRHP on 30 December 2024, RHP on 16 July 2025, and Prospectus on 29 July 2025, listing on BSE under ticker 544460 with a reported share price of ₹91 in April 2026. Headcount stands at 51-100 employees, indicating small-cap status. Revenue is not disclosed in available sources. No acquisitions, partnerships, leadership changes beyond post-IPO board governance, or new product launches outside the existing branded line have been recorded; expansion signals are limited to IPO proceeds, exhibition activity, and existing regulatory credentials.

Short descriptiontext

Patel Chem Specialities Limited, founded in 2008 and based in Ahmedabad, India, manufactures and exports seven branded pharmaceutical excipients (cellulose ethers, superdisintegrants, fillers, lubricants) and Sodium Chloro Acetate to pharmaceutical and nutraceutical formulators under GMP, ISO, and FDA-certified operations, and listed on BSE in 2025.

Operating statusenum
Ipo
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersAhmedabad, India
HQ citystring
Ahmedabad
HQ countrystring
India
HQ regionstring
Asia
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical excipients, cellulose derivatives, superdisintegrants, tablet formulation ingredients, specialty chemicals
Industry2 codes
PRIMARYCRADAOAD
Hydrocolloids, Thickeners & Gelling Agents (Pectin, Xanthan, Carrageenan, Gelatin)
SECONDARYIMANABAK
Medical & Food-Contact Specialty Compounds
NAICS code1 code
  • Chemical Manufacturing325
SIC code1 code
  • Medicinal Chemicals & Botanical Products2833
Product category
Pharmaceutical Excipients
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
Pricing details1 tier
1Sample product pricing displayed on website
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Sample prices shown: X3 product at $100.00, X2 product at $70.00. These appear to be placeholder values rather than actual product pricing.

patelchem.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 8 records shown
1Rheollose®
Description

Carboxymethyl Cellulose Sodium - Cellulose Gum used as anionic water-soluble polymer in pharmaceutical applications

patelchem.com
+7 more records
Core offering1 text field

Patel Chem Specialities Limited manufactures and exports pharmaceutical-grade excipients including Carboxymethyl Cellulose Sodium, Croscarmellose Sodium, Sodium Starch Glycolate, Calcium CMC, Microcrystalline Cellulose, Magnesium Stearate, and Pregelatinized Starch, along with the specialty chemical Sodium Chloro Acetate. Products are supplied as functional ingredients (superdisintegrants, binders, fillers, lubricants) for pharmaceutical, nutraceutical, food, and chemical manufacturers. The company operates from a GMP/ISO/FDA-certified manufacturing facility in Ahmedabad, Gujarat, India.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Patel Chem Specialities Limited is a GMP & ISO Certified and FDA Approved Manufacturer-Exporter of pharmaceutical excipients and speciality chemicals. The company's product portfolio consists of seven branded pharmaceutical excipients (Rheollose®, Disolwell®, BlowTab®, Swellcal®, Hindcel®, PharLub™, and AmyloTab™ C) and one specialty chemical (Sodium Chloro Acetate). These products serve as critical functional ingredients in tablet manufacturing, including superdisintegrants (Croscarmellose Sodium, Sodium Starch Glycolate, Calcium CMC), binders and fillers (Microcrystalline Cellulose, Pregelatinized Starch), lubricants (Magnesium Stearate), and cellulose ethers (Carboxymethyl Cellulose Sodium).

Product and service1 record
1Rheollose® - Carboxymethyl Cellulose Sodium
Scale indicator1 record

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

India-based manufacturer of pharmaceutical excipients including microcrystalline cellulose, croscarmellose sodium, and magnesium stearate with multi-pharmacopeial compliance; one of the closest direct comparables by product mix, regulatory positioning, and Indian manufacturing base.

2DuPont (now IFF Health & Biosciences)
TypeBroad incumbent
Description

Global leader in pharmaceutical excipients with the Avicel® microcrystalline cellulose brand and a full excipients portfolio; competes directly in MCC, CMC, and croscarmellose markets but offers broader scale, services, and a wider product catalog.

TypeBroad incumbent
Description

Specialty chemical manufacturer with a major pharmaceutical excipients business spanning cellulose derivatives, superdisintegrants, and binders; directly comparable on chemistry but operates at far larger global scale with broader formulation support services.

TypeBroad incumbent
Description

Pharmaceutical excipient division of J. Rettenmaier & Söhne producing MCC, CMC, and starch-based excipients; competes in the same cellulose derivative chemistries with strong presence in Europe and global formulation support capabilities.

TypeBroad incumbent
Description

French global manufacturer of pharmaceutical excipients including cyclodextrins, starch derivatives, and cellulose-based products; competes in starch-based chemistries (pregelatinized starch, sodium starch glycolate) at a significantly larger global scale.

TypeBroad incumbent
Description

Specialized pharmaceutical excipient manufacturer with focus on dry powder inhalation and oral dose excipients; competes in MCC, starch, and superdisintegrant categories with strong regulatory dossiers and global supply network.

TypeDirect peer
Description

India-based manufacturer of pharmaceutical excipients and ready-to-use coating systems; comparable in product scope (cellulose derivatives, superdisintegrants) and in targeting Indian and export pharma customers from an India manufacturing base.

TypeDirect peer
Description

Indian manufacturer and exporter of pharmaceutical excipients and APIs with GMP and ISO certifications; comparable as a mid-sized India-based excipient producer targeting regulated export markets with multi-pharmacopeial products.

9Anhui Sunhere Pharmaceutical Excipients
TypeEmerging player
Description

Chinese manufacturer of pharmaceutical-grade excipients including microcrystalline cellulose, starch derivatives, and pregelatinized starch; competes on price in the same cellulose/starch chemistries primarily in Asian and emerging markets.

TypeEmerging player
Description

China-based pharmaceutical excipient manufacturer producing CMC, MCC, and other cellulose derivatives; competes as a low-cost alternative to Indian suppliers in the same commoditized chemistries with growing regulatory certifications.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Patel Chem Specialities

Pharmaceutical Excipientspcspl.net

Patel Chem Specialities Limited, founded in 2008 and based in Ahmedabad, India, manufactures and exports seven branded pharmaceutical excipients (cellulose ethers, superdisintegrants, fillers, lubricants) and Sodium Chloro Acetate to pharmaceutical and nutraceutical formulators under GMP, ISO, and FDA-certified operations, and listed on BSE in 2025.

What Patel Chem Specialities does

Patel Chem Specialities Limited is an Indian pharmaceutical excipient manufacturer and exporter, founded in 2008 and headquartered at GIDC Estate, Vatva, Ahmedabad, Gujarat. The company operates a single GMP-, ISO-, and FDA-certified manufacturing facility producing eight products: seven branded pharmaceutical excipients — Rheollose® (Carboxymethyl Cellulose Sodium), Disolwell® (Croscarmellose Sodium), BlowTab® (Sodium Starch Glycolate), Swellcal® (Calcium CMC), Hindcel® (Microcrystalline Cellulose), PharLub™ (Magnesium Stearate), and AmyloTab™ C (Pregelatinized Starch) — plus the specialty chemical Sodium Chloro Acetate. The portfolio covers superdisintegrants, binders/fillers, lubricants, and cellulose ethers, with multi-pharmacopeial compliance (IP, BP, EP, USP-NF, JP) enabling sales into both domestic Indian formulation manufacturers and export markets. The company also holds Halal India certification and an Indian Drug License, supporting nutraceutical and food-industry adjacencies.

The business operates as a B2B direct-sales manufacturer selling excipient inputs to pharmaceutical and nutraceutical formulators for tablet and capsule production. Pricing is quote-based rather than publicly listed, consistent with B2B specialty chemicals. Go-to-market relies on trade-show participation (CPHI & PMEC India 2024, FI India 2024) and a corporate website, with no distribution intermediaries. The company filed its DRHP on 30 December 2024, RHP on 16 July 2025, and Prospectus on 29 July 2025, listing on BSE under ticker 544460 with a reported share price of ₹91 in April 2026. Headcount stands at 51-100 employees, indicating small-cap status. Revenue is not disclosed in available sources. No acquisitions, partnerships, leadership changes beyond post-IPO board governance, or new product launches outside the existing branded line have been recorded; expansion signals are limited to IPO proceeds, exhibition activity, and existing regulatory credentials.

Patel Chem Specialities firmographics

Firmographics
Name
Patel Chem Specialities
Legal name
Patel Chem Specialities Limited
Website
https://pcspl.net
Company type
Public
Founded year
2008
Operating status
Ipo
Headcount range
51–100 employees
Short description
Patel Chem Specialities Limited, founded in 2008 and based in Ahmedabad, India, manufactures and exports seven branded pharmaceutical excipients (cellulose ethers, superdisintegrants, fillers, lubricants) and Sodium Chloro Acetate to pharmaceutical and nutraceutical formulators under GMP, ISO, and FDA-certified operations, and listed on BSE in 2025.
Ownership category
akta.pro rank

Patel Chem Specialities industry classification

Industry
Product category
Pharmaceutical Excipients
NAICS
Chemical Manufacturing (325)
SIC
Medicinal Chemicals & Botanical Products (2833)
akta.pro industry
PRIMARYCRADAOAD
Hydrocolloids, Thickeners & Gelling Agents (Pectin, Xanthan, Carrageenan, Gelatin)
SECONDARYIMANABAK
Medical & Food-Contact Specialty Compounds

Keywords

  • Pharmaceutical excipients
  • Cellulose derivatives
  • Superdisintegrants
  • Tablet formulation ingredients
  • Specialty chemicals

Where Patel Chem Specialities is headquartered

Location

Headquarters

HQ city
Ahmedabad
HQ country
India
HQ region
Asia

Offices1 record

Markets served

Patel Chem Specialities business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goSample product pricing displayed on website

Distribution channels1 record

Marketing channels3 records

Patel Chem Specialities product offering

Product offering

Core offering

Patel Chem Specialities Limited manufactures and exports pharmaceutical-grade excipients including Carboxymethyl Cellulose Sodium, Croscarmellose Sodium, Sodium Starch Glycolate, Calcium CMC, Microcrystalline Cellulose, Magnesium Stearate, and Pregelatinized Starch, along with the specialty chemical Sodium Chloro Acetate. Products are supplied as functional ingredients (superdisintegrants, binders, fillers, lubricants) for pharmaceutical, nutraceutical, food, and chemical manufacturers. The company operates from a GMP/ISO/FDA-certified manufacturing facility in Ahmedabad, Gujarat, India.

Product overview

Patel Chem Specialities Limited is a GMP & ISO Certified and FDA Approved Manufacturer-Exporter of pharmaceutical excipients and speciality chemicals. The company's product portfolio consists of seven branded pharmaceutical excipients (Rheollose®, Disolwell®, BlowTab®, Swellcal®, Hindcel®, PharLub™, and AmyloTab™ C) and one specialty chemical (Sodium Chloro Acetate). These products serve as critical functional ingredients in tablet manufacturing, including superdisintegrants (Croscarmellose Sodium, Sodium Starch Glycolate, Calcium CMC), binders and fillers (Microcrystalline Cellulose, Pregelatinized Starch), lubricants (Magnesium Stearate), and cellulose ethers (Carboxymethyl Cellulose Sodium).

Differentiator

Problem solved

Functional benefit

Brands

  • Rheollose®: Carboxymethyl Cellulose Sodium - Cellulose Gum used as anionic water-soluble polymer in pharmaceutical applications
  • Disolwell®
  • BlowTab®
  • Swellcal®
  • Hindcel®
  • PharLub™
  • AmyloTab™ C
  • Patel Chem

Products and services

  • Rheollose® - Carboxymethyl Cellulose Sodium

Companies that use Patel Chem Specialities

Customer profile

Segments4 records

Ideal customer profiles3 records

Patel Chem Specialities technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature8 records

Patel Chem Specialities partnerships and signals

Strategic signal

Scale indicators1 record

Recent moves6 records

Expansion highlights5 records

Patel Chem Specialities competitors and assessment

Company assessment

Direct peers

  • Sigachi Industries: India-based manufacturer of pharmaceutical excipients including microcrystalline cellulose, croscarmellose sodium, and magnesium stearate with multi-pharmacopeial compliance; one of the closest direct comparables by product mix, regulatory positioning, and Indian manufacturing base.
  • Ideal Cures: India-based manufacturer of pharmaceutical excipients and ready-to-use coating systems; comparable in product scope (cellulose derivatives, superdisintegrants) and in targeting Indian and export pharma customers from an India manufacturing base.
  • Corel Pharma Chem: Indian manufacturer and exporter of pharmaceutical excipients and APIs with GMP and ISO certifications; comparable as a mid-sized India-based excipient producer targeting regulated export markets with multi-pharmacopeial products.

Broad incumbents

  • DuPont (now IFF Health & Biosciences): Global leader in pharmaceutical excipients with the Avicel® microcrystalline cellulose brand and a full excipients portfolio; competes directly in MCC, CMC, and croscarmellose markets but offers broader scale, services, and a wider product catalog.
  • Ashland: Specialty chemical manufacturer with a major pharmaceutical excipients business spanning cellulose derivatives, superdisintegrants, and binders; directly comparable on chemistry but operates at far larger global scale with broader formulation support services.
  • JRS Pharma: Pharmaceutical excipient division of J. Rettenmaier & Söhne producing MCC, CMC, and starch-based excipients; competes in the same cellulose derivative chemistries with strong presence in Europe and global formulation support capabilities.
  • Roquette: French global manufacturer of pharmaceutical excipients including cyclodextrins, starch derivatives, and cellulose-based products; competes in starch-based chemistries (pregelatinized starch, sodium starch glycolate) at a significantly larger global scale.
  • DFE Pharma: Specialized pharmaceutical excipient manufacturer with focus on dry powder inhalation and oral dose excipients; competes in MCC, starch, and superdisintegrant categories with strong regulatory dossiers and global supply network.

Emerging players

  • Anhui Sunhere Pharmaceutical Excipients: Chinese manufacturer of pharmaceutical-grade excipients including microcrystalline cellulose, starch derivatives, and pregelatinized starch; competes on price in the same cellulose/starch chemistries primarily in Asian and emerging markets.
  • Hunan Er-Kang Pharmaceutical: China-based pharmaceutical excipient manufacturer producing CMC, MCC, and other cellulose derivatives; competes as a low-cost alternative to Indian suppliers in the same commoditized chemistries with growing regulatory certifications.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Patel Chem Specialities social profiles

Digital presence

Patel Chem Specialities compliance and trust

Trust signal

Compliance4 records

Patel Chem Specialities financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Patel Chem Specialities leadership team

Management profile

Number of profiles

Patel Chem Specialities funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Patel Chem Specialities M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Patel Chem Specialities

What does Patel Chem Specialities do?

Patel Chem Specialities Limited manufactures and exports pharmaceutical-grade excipients including Carboxymethyl Cellulose Sodium, Croscarmellose Sodium, Sodium Starch Glycolate, Calcium CMC, Microcrystalline Cellulose, Magnesium Stearate, and Pregelatinized Starch, along with the specialty chemical Sodium Chloro Acetate. Products are supplied as functional ingredients (superdisintegrants, binders, fillers, lubricants) for pharmaceutical, nutraceutical, food, and chemical manufacturers. The company operates from a GMP/ISO/FDA-certified manufacturing facility in Ahmedabad, Gujarat, India.

Is Patel Chem Specialities a public or private company?

Patel Chem Specialities is a public company. It is classified as public and is currently ipo.

When was Patel Chem Specialities founded?

Patel Chem Specialities was founded in 2008. It employs 51 to 100 people.

Where is Patel Chem Specialities based?

Patel Chem Specialities is headquartered in Ahmedabad, India, in the Asia region.

Who are Patel Chem Specialities's main competitors?

Direct peers on record are Sigachi Industries, Ideal Cures and Corel Pharma Chem. Broad incumbents are DuPont (now IFF Health & Biosciences), Ashland, JRS Pharma, Roquette and DFE Pharma. Emerging players are Anhui Sunhere Pharmaceutical Excipients and Hunan Er-Kang Pharmaceutical.

Does Patel Chem Specialities have an API?

No public API is recorded for Patel Chem Specialities.

What industry is Patel Chem Specialities in?

Patel Chem Specialities's product category is Pharmaceutical Excipients. Its primary akta.pro industry code is CRADAOAD, Hydrocolloids, Thickeners & Gelling Agents (Pectin, Xanthan, Carrageenan, Gelatin), with a secondary code of IMANABAK, Medical & Food-Contact Specialty Compounds. Its NAICS code is 325 and its SIC code is 2833.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
ScanXPatel Chem Specialities seeks waiver of ₹1.23 lakh BSE fine for filing lapsePatel Chem Specialities requested the Bombay Stock Exchange to waive a ₹1,22,720 fine for non-compliance with SEBI Regulation 34. The company cited an inadvertent delay in filing its Annual Report, and the Board directed management to strengthen internal compliance monitoring.ScanXPatel Chem Specialities fined ₹1.22 lakh by BSE for filing errorBSE fined Patel Chem Specialities ₹1,22,720 for alleged non-compliance with SEBI LODR Regulation 34 over the FY26 annual report. The company claims the report was uploaded on time, citing an inadvertent error in selecting the financial year parameter. Management is seeking a waiver, stating no impact on operations.ScanXPatel Chem Specialities expands Talod plant capacity to 4,500 MTPatel Chem Specialities expanded its Talod plant capacity from 720 MT to 4,500 MT per annum, a sixfold increase. The ₹20 crore capital expenditure, funded by loans and accruals, has commenced trial batches, with commercial production expected shortly. The expansion aims to meet anticipated demand and shorten delivery schedules.ScanXPatel Chem Specialities to join Arihant Bharat Connect conferencePatel Chem Specialities will attend the Arihant Bharat Connect Conference Rising Star on September 30, 2026, a virtual investor meeting. The company confirmed no unpublished price-sensitive information will be shared, complying with SEBI regulations. The participation aims to enhance investor engagement and market visibility.ScanXPatel Chem Specialities fixes Sep 18 record date for AGM e-votingPatel Chem Specialities fixed September 18, 2026 as the record date for shareholder eligibility for remote e-voting at its Annual General Meeting. The AGM is scheduled for September 25, 2026, and the record date applies to equity shares with scrip code 544460.PR NewswireCarboxymethylcellulose Calcium Market worth $0.09 billion by 2036 - Exclusive Report by MarketsandMarkets™The global carboxymethylcellulose calcium market is projected to grow from USD 0.06 billion in 2026 to USD 0.09 billion by 2036, a CAGR of 4.8%. Asia Pacific is expected to see the highest growth at 5.2%, with the fine powder segment holding a 58% value share in 2025.ScanXPatel Chem Specialities FY26 Results: Revenue up 31%, net profit rises 19%Patel Chem Specialities reported FY26 revenue of ₹1,372.6 crore, up 30.6% year-on-year, and net profit of ₹125.5 crore, up 18.7%. EBITDA rose 20.1% to ₹188.9 crore, but EBITDA margin fell to 13.6% from 15.0%. The company raised ₹58.8 crore via IPO and plans a new Mehsana facility.ScanXPatel Chem Specialties schedules board meeting for September 1Patel Chem Specialities has scheduled a board meeting for September 1, 2026, to approve FY26 financial results and the Directors Report, re-appoint Mrs. Anshu Bhupesh Patel as director, and set the AGM date, time, venue and record date. The company also appointed a Scrutinizer for e-voting and considered the Secretarial Auditor's Report for FY25-26.